Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
about
Does intentional weight loss improve daytime sleepiness? A systematic review and meta-analysis.Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.Liraglutide for weight management: a critical review of the evidence.Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects.Epidemiology of Obesity and Pharmacologic Treatment Options.Obstructive Sleep Apnea and Diabetes: A State of the Art Review.Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials.Weight loss after laparoscopic adjustable gastric band and resolution of the metabolic syndrome and its components.The relationship between sleep and glucagon-like peptide 1 in patients with abnormal glucose tolerance.Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials.Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis.Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK.Centrally Acting Agents for Obesity: Past, Present, and Future
P2860
Q30238808-79DB966C-7793-49DB-AACF-AFA1A205D151Q30400748-3F5EDDF1-6421-4193-A9AA-72EEB10571A9Q37711170-C51F3EA1-7148-4F9D-9394-8398009DAA16Q38385024-8481104F-749C-4405-A7DB-28A92FE1F8D1Q38717129-34C12347-2F46-4BEE-A992-B8797095A2B5Q38773146-90B92453-29FA-4DED-B98E-0480DBF43A38Q38794395-B17A4548-93A1-413A-B8F8-E194850EF16EQ38848626-65E0E5B0-871C-41A3-8DBD-7F7B7C4ABB80Q38927663-B7485BEC-D435-4C5A-BEF9-5EEDB7E82853Q40179514-F56E36BB-595E-4245-87C7-1D7B4566B74DQ47918439-34AEB6EF-5ED7-4C69-AAD3-4795B65BF6FAQ49962233-5110E8C4-0E80-4FD5-AEDF-B4139752CC46Q55235007-30C77951-5973-4649-BD2E-D0D24DCDBA19Q57177981-6346C2D3-99F3-4FDF-99E3-813CEFC9881E
P2860
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of liraglutide 3.0 mg i ...... pnea randomized clinical trial
@en
Effect of liraglutide 3.0 mg i ...... nea randomized clinical trial.
@nl
type
label
Effect of liraglutide 3.0 mg i ...... pnea randomized clinical trial
@en
Effect of liraglutide 3.0 mg i ...... nea randomized clinical trial.
@nl
prefLabel
Effect of liraglutide 3.0 mg i ...... pnea randomized clinical trial
@en
Effect of liraglutide 3.0 mg i ...... nea randomized clinical trial.
@nl
P2093
P2860
P356
P1476
Effect of liraglutide 3.0 mg i ...... pnea randomized clinical trial
@en
P2093
A Blackman
B Claudius
C B Jensen
G D Foster
R Rosenberg
P2860
P2888
P304
P356
10.1038/IJO.2016.52
P407
P577
2016-03-23T00:00:00Z